Humana Inc. (NYSE:HUM – Free Report) – Zacks Research cut their Q3 2025 earnings per share estimates for shares of Humana in a report issued on Thursday, September 19th. Zacks Research analyst D. Chatterjee now anticipates that the insurance provider will earn $4.83 per share for the quarter, down from their prior forecast of $4.84. The consensus estimate for Humana’s current full-year earnings is $16.00 per share. Zacks Research also issued estimates for Humana’s Q4 2025 earnings at $1.61 EPS.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $8.94 earnings per share.
Humana Stock Performance
Humana stock opened at $312.74 on Monday. The firm has a fifty day simple moving average of $356.28 and a two-hundred day simple moving average of $345.36. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana has a twelve month low of $298.61 and a twelve month high of $530.54. The company has a market capitalization of $37.69 billion, a PE ratio of 19.47, a P/E/G ratio of 2.56 and a beta of 0.50.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Mendota Financial Group LLC boosted its position in shares of Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 27 shares during the last quarter. Aurora Investment Counsel increased its holdings in shares of Humana by 1.3% in the fourth quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock worth $1,155,000 after purchasing an additional 29 shares during the last quarter. Capital Advisors Ltd. LLC lifted its position in shares of Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after buying an additional 31 shares in the last quarter. EP Wealth Advisors LLC boosted its stake in Humana by 1.6% during the fourth quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock valued at $1,050,000 after buying an additional 37 shares during the last quarter. Finally, CarsonAllaria Wealth Management Ltd. grew its holdings in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.13%. The ex-dividend date is Monday, September 30th. Humana’s dividend payout ratio is currently 22.04%.
Humana Company Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- What is the Hang Seng index?
- The Average 401k Balance by Age Explained
- What is Put Option Volume?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- ETF Screener: Uses and Step-by-Step Guide
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.